Pietro Pola
Via Luigi Borsari 46
Ferrara, 44121, Italy
Ferrara, 44121, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Design of New Potent, Selective, and Long-Acting NOP Receptor Agonists through Multiple Sequential d-Amino Acid Substitutions of [Arg14 Lys15]N/OFQ(1-15)-NH2.
Journal: Journal of medicinal chemistry
Published: July 23, 2026
NOP receptor activation counteracts stress-induced migraine-like behaviors in mice.
Journal: Neuropharmacology
Published: April 07, 2026
Systematic comparison of GTN- and CGRP-induced migraine-like behaviors across sex and strain in mice.
Journal: Behavioural brain research
Published: March 27, 2026
Synthesis and Pharmacological Characterization of Nociceptin/Orphanin FQ Dimeric Ligands.
Journal: Journal of medicinal chemistry
Published: November 04, 2025
Sex differences in response to NLRP3 inflammasome blockage in a mouse migraine model: A genetic and pharmacological study.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: April 29, 2025
Activation of peripheral NOP receptors reduces periorbital mechanical allodynia evoked by CGRP in mice.
Journal: British journal of pharmacology
Published: April 10, 2025
In vitro pharmacological evaluation of the novel NOP receptor partial agonist sunobinop.
Journal: Biochemical pharmacology
Published: March 28, 2025
Effects of Stress Exposure to Pain Perception in Pre-Clinical Studies: Focus on the Nociceptin/Orphanin FQ-NOP Receptor System.
Journal: Brain sciences
Published: July 15, 2024
In vitro pharmacological characterization of growth hormone secretagogue receptor ligands using the dynamic mass redistribution and calcium mobilization assays.
Journal: European journal of pharmacology
Published: May 13, 2024
Showing 1-9 of 9
Last Updated: 09/26/2026